# Insulin Resistance in Pulmonary Arterial Hypertension

> **NCT00825266** · PHASE2 · TERMINATED · sponsor: **Stanford University** · enrollment: 2 (actual)

## Conditions studied

- Hypertension, Pulmonary

## Interventions

- **DRUG:** bosentan
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00825266
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-09
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** difficulty in finding eligible subjects
- **Last updated:** 2017-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00825266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00825266, "Insulin Resistance in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00825266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*